Drugstore Chain Suing Generic Manufacturer Over Reglan Tardive Dyskinesia

Ryan Green | August 3rd, 2011 | Posted in Reglan Lawsuit News

Drugstore chain Rite Aid has been wrongly harmed by India-based Ranbaxy Laboratories, or at least that’s what the US based company alleges. Rite Aid is suing Ranbaxy to recover costs it has accrued as a direct result of Reglan lawsuits brought to court by patients who suffered Reglan tardive dyskinesia after taking the commonly prescribed heartburn and nausea drug.

Reglan tardive dyskinesia results in Reglan lawsuits against additional defendants

Reglan lawsuits are no longer limited to injured patients seeking compensation from drug companies. According to Rite Aid, some Reglan lawsuits have claimed that it is not only the drug companies that made and distributed the medication, but also the pharmacies that sold it, that are liable for inadequately warning patients about the serious risks of Reglan tardive dyskinesia, an incurable, Tourette’s-like movement disorder.

Reglan lawsuits prompt Rite Aid lawsuit response

Rite Aid is not suing Wyeth, the maker of the “brand name” Reglan, but only Ranbaxy, the manufacturer of a generic version of Reglan, known as Metaclopramide. According to the suit filed in the US Eastern District Court of Pennsylvania, Ranbaxy has violated its contract with Rite Aid by refusing to defend it against Reglan lawsuits. Rite Aid claims that its agreement with the generic drug maker requires “Ranbaxy to defend, indemnify and hold Rite Aid, its shareholders, officers, agents and subsidiaries from any and all losses”.

The official complaint in the court file additionally declares that, “”Rite Aid seeks compensatory damages with a present monetary value … in excess of $75,000.”

Majority of Reglan lawsuits filed over multiple Reglan side effects

The vast majority of Reglan lawsuits pending in U.S. federal and state courts have been filed by patients who took Reglan or its generic form metaclopramide, and suffered side effects that include not only Reglan tardive dyskinesia, but also Neuroleptic Malignant Syndrome, secondary Parkinsons disease symptoms, blepharospasm, ocular deviation, depression, anxiety, fatigue, vertigo and hair loss.

Reglan lawsuits centralized in New Jersey Superior Court

Reglan lawsuits filed by a Reglan lawyer in state courts across the country have been centralized for pre-trial management in New Jersey Superior Court. Judge Carol E. Higbee, a veteran of mass torts involving such controversial drugs as Accutane and Levaquin, will oversee the pre-trial stages of Reglan lawsuits, which currently number over 1000. Reglan lawsuits are advancing steadily under the oversight of Judge Higbee, with oral arguments in regard to various pre-trial motions scheduled to be heard on September 2, 2011.